2021
DOI: 10.46683/jmvi.2020.17
|View full text |Cite
|
Sign up to set email alerts
|

Production and Distribution of mRNA Vaccines: SARS-CoV-2 Experience

Abstract: ÖzetSARS-CoV-2 (Severe acute respiratory syndrome coronavirus) pandemisi dünya genelinde daha önce benzeri hiç görülmemiş bir aşı talebi oluşturdu. Bu talebi karşılamak için, çok sayıda ticari firma ve kurumsal işletme yeni nesil platform teknolojilerini (mesajcı ribonükleik asit-mRNA ve vektör temelli aşılar) veya geleneksel üretim yaklaşımlarını (subünit ve inaktive aşılar) temel alarak aşı geliştirme çalışmalarına odaklandı. Bu stratejiler arasında mRNA platformunu kullanan bazı aşılar faz III çalışmalarını… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 3 publications
0
1
0
Order By: Relevance
“…In a review article describing the production and distribution of mRNA vaccines in the COVID-19 process, production scales of SARS-CoV-2 RNA vaccines and mRNA vaccine production against new agents were mentioned. In this review, the topicality of the mRNA vaccine was emphasized (22).…”
Section: Resultsmentioning
confidence: 99%
“…In a review article describing the production and distribution of mRNA vaccines in the COVID-19 process, production scales of SARS-CoV-2 RNA vaccines and mRNA vaccine production against new agents were mentioned. In this review, the topicality of the mRNA vaccine was emphasized (22).…”
Section: Resultsmentioning
confidence: 99%